KLISBio
PrivateLast Round
Grant
Feb 28, 2024
Total Funding Raised
$11.34M
Company Overview
KLISBio is a biotechnology company that develops implantable regenerative medical solutions powered by silk fibroin for soft tissue repair.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KLISBio Comparables
Compare KLISBio with similar companies based on industry and business-model similarity.
KLISBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 28, 2024 | ||||
| Series A | Apr 21, 2016 | ||||
| Angel | Dec 1, 2015 | ||||
| Grant | Dec 5, 2014 |
Key People
Founding team and executive leadership
KLISBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Principia SGR | Series A |
KLISBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KLISBio's valuation, stock price, and market status.